Who are we?
NAPM is originally a Section 21 Trade Association which was established in 1977. It was incorporated as a non profit organization in terms of the amendment to the Companies Act of 2008.
It is a voluntary, non-profit organisation consisting of South African and Generics based Pharmaceutical manufacturers and distributors. NAPM has a diverse membership comprising of 24 companies. Some of the NAPM’s function is to ensure that the sector plays a constructive role in our country’s economic growth, development and transformation and thereby create an environment in which the sector can thrive, expand, be competitive and enhance access of medicines to all of our country’s citizens.
NAPM supports Government’s initiative of Accelerated Shared Growth Initiative SA (ASGISA) and in particular shared growth to address the twin challenges of unemployment and poverty alleviation and the economic growth rate required to meet these two challenges. NAPM is a full member of the IGBA and SAGMA.
Our mission and vision
We aim to champion affordable and accessible healthcare by promoting generic and biosimilar medicines and supporting the development of the South African pharmaceutical industry as a national asset. We also aim to contribute to the efficiency of the regulatory system which will in turn help speed up the registration of drugs.
Our Objective
To promote the use of Generic Medicines and Biosimilars
Create greater access to medicines for patients
Strengthen the NAPM Membership
Develop the local pharmaceutical industry as a whole
Our Board
Melinda Badenhorst
Desmond Brothers –Immediate past Chairperson
Muhammad Bodhania
Suhail Gani
Lorraine Keyser – Vice Chairperson
Herman Grobler – Chairperson
Reshlan Nagoor
Mervin Naidoo
Erik Roos
Vineet Shiva
Anita Smal
Guillaume Van Niekerk
Sub-Committees
Science / Regulatory/ Biosimilars Committee
Trade and Industry / Tenders Committee
Marketing Committee
Intellectual Property Committee
Pricing /Market Access Committee
CAMS Committee